CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1. Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Rising incidence of chronic diseases & geriatric population
4.1.2. Technological advancements for manufacturing customized products
4.1.3. High demand for organ transplantation
4.1.4. Rise in public and private funding to support 3D bio printing research activities
4.2. Market Restraints & Challenges
4.2.1. Lack of complete automation
4.2.2. Dearth of trained professionals and high initial costs
4.3. Market Opportunities
4.3.1. Growing awareness related to 3D bio printing
4.3.2. Increasing stem cell research
4.3.3. High usage of 3D printing in cosmetic surgeries
CHAPTER 5 GLOBAL 3D BIOPRINTING MARKET – BY MATERIAL
5.1. Introduction
5.2. Hydrogels
5.3. Extracellular matrices
5.4. Living cells
5.5. Other biomaterials
CHAPTER 6 GLOBAL 3D BIOPRINTING MARKET – BY TECHNOLOGY
6.1. Introduction
6.2. Micro extrusion bio printing
6.3. Inkjet 3D bio printing
6.4. Laser-assisted bio printing
6.5. Magnetic 3D bio printing
6.6. Others (Syringe-based 3D Bio printing and Pneumatic Extrusion-based 3D Bio printing)
CHAPTER 7 GLOBAL 3D BIOPRINTING MARKET – BY APPLICATION
7.1. Introduction
7.2. Research
7.3. Drug Testing & Development
7.4. Regenerative Medicine
7.5. Food Testing
7.6. Others
CHAPTER 8 GLOBAL 3D BIOPRINTING MARKET – BY END-USER
8.1. Pharmaceutical & Biotechnology Companies
8.2. Research Organizations
8.3. Academic Institutions
CHAPTER 9 GLOBAL 3D BIOPRINTING MARKET - BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. Asia Pacific
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10 GLOBAL 3D BIOPRINTING MARKET - COMPANY PROFILES
10.1. Organovo Holdings, Inc.
10.2. Cellink AB.
10.3. Bio3D Technologies.
10.4. Aspect Bio Systems Ltd.
10.5. Stratasys Ltd.
10.6. Materialise NV.
10.7. ENVISIONTEC, INC.
10.8. Nano3D Biosciences, Inc.
10.9. Cyfuse Biomedical K.K.
10.10. 3Dynamic Systems Ltd.
10.11. Regenhu SA,
10.12. Cayman Chemical Company
10.13. GFS Chemicals, Inc.
10.14. Chiron As.
CHAPTER 11 GLOBAL 3D BIOPRINTING MARKET - COMPETITIVE LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12 MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13 APPENDIX
13.1. List of Tables
13.2. List of Figures
